Vivos (RDGL) Change in Inventory (2010 - 2025)

Vivos (RDGL) reported Change in Inventory of -$5477.0 for Q4 2025, down 2312.78% sequentially from -$227.0 in Q3 2025.

Vivos (RDGL) Change in Inventory (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 5 years of Change in Inventory data on file, last reported at -$5477.0 in Q4 2025.

For the quarter ending Q4 2025, Change in Inventory changed N/A year-over-year to -$5477.0; the trailing twelve-month figure through Dec 2025 stood at $57257.0 (changed N/A YoY), and the FY2025 full-year result was $57257.0, changed N/A from the prior year.
Change in Inventory retreated to -$5477.0 in Q4 2025, from -$227.0 in the prior quarter.
In the past five years, Change in Inventory ranged from a high of $41763.0 in Q2 2025 to a low of -$5477.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Abbott Laboratories	183.91 Bn	176.62 Bn	6.27 Bn	420.00 Mn
2	Stryker	128.87 Bn	125.99 Bn	3.81 Bn	127.00 Mn
3	Medtronic	108.72 Bn	99.50 Bn	6.41 Bn	-399.00 Mn
4	Boston Scientific	68.46 Bn	67.01 Bn	3.61 Bn	177.00 Mn
5	Edwards Lifesciences	48.53 Bn	44.85 Bn	1.29 Bn	1.60 Mn
6	Dexcom	28.37 Bn	27.25 Bn	750.30 Mn	65.20 Mn
7	GE HealthCare Technologies	28.34 Bn	26.06 Bn	1.98 Bn	171.00 Mn
8	Smith & Nephew	26.91 Bn	26.33 Bn	-	-
9	Koninklijke Philips	25.47 Bn	22.34 Bn	2.07 Bn	-264.59 Mn
10	Vivos	26.71 Mn	25.15 Mn	-3,105.00	-5,477.00

Download Data